United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 16, 2026 · Filed Apr 17, 2026

On Apr 16, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$577.21 for US$5.48M under a trading plan, leaving 40,513 shares. Filed Apr 17, 2026 (Form 4).

Sold
9,500 shares
Price
US$577.21 average (US$573.96 to US$581.33)
Value
US$5.48M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 16, 2026Common StockSale400US$573.9649,613Direct
Apr 16, 2026Common StockSale1,800US$574.7947,813Direct
Apr 16, 2026Common StockSale930US$575.9946,883Direct
Apr 16, 2026Common StockSale2,048US$577.0344,835Direct
Apr 16, 2026Common StockSale2,027US$578.0542,808Direct
Apr 16, 2026Common StockSale1,750US$579.3641,058Direct
Apr 16, 2026Common StockSale385US$579.8440,673Direct
Apr 16, 2026Common StockSale160US$581.3340,513Direct

Source

View original at SEC

Related